Mihnea Miron, Mihaela Blaj, Anca Irina Ristescu, Gabriel Iosep, Andrei-Nicolae Avădanei, Diana-Gabriela Iosep, Radu Crișan-Dabija, Alexandra Ciocan, Mihaela Perțea, Carmen Doina Manciuc, Ștefana Luca, Cristina Grigorescu, Mihaela Cătălina Luca
Hospital-acquired pneumonia (HAP) and its subtype, ventilator-associated pneumonia (VAP), remain two significant causes of morbidity and mortality worldwide, despite the better understanding of pathophysiological mechanisms, etiology, risk factors, preventive methods (bundle of care principles) and supportive care. Prior detection of the risk factors combined with a clear clinical judgement based on clinical scores and dosage of different inflammatory biomarkers (procalcitonin, soluble triggering receptor expressed on myelloid cells type 1, C-reactive protein, mid-regional pro-adrenomedullin, mid-regional pro-atrial natriuretic peptide) represent the cornerstones of a well-established management plan by improving patient's outcome...
January 20, 2024: Microorganisms